UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

COPD exacerbation frequency and its association with health care resource utilization and costs

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.2609-2618

2015

Volltextzugriff (PDF)

The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review

Applied health economics and health policy, 2015-08, Vol.13 (Suppl 1), p.21-33

2015

Volltextzugriff (PDF)

PB2109: REALMIND: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA STARTING SECOND/THIRD‐LINE THERAPY AND NOT RECEIVING A STEM CELL TRANSPLANT

HemaSphere, 2022-06, Vol.6 (Suppl), p.1980-1981

2022

Volltextzugriff (PDF)

Us Burden of Illness Associated With Adjuvant Therapy for Stage I-III Melanoma

Value in health, 2015-05, Vol.18 (3), p.A215-A215

2015

Volltextzugriff (PDF)

Consideration of international generic distribution policies on patient outcomes in the United States and Germany

Pharmazie, 2014-03, Vol.69 (3), p.238-240

2014

Volltextzugriff (PDF)

The Impact of Generic Substitution on Health Outcomes and Costs: A Systematic Review

Value in health, 2013-11, Vol.16 (7), p.A458-A458

2013

Volltextzugriff (PDF)

PHP13 Impact of Medicare Part D on Pharmaceutical and Medical Utilization in Arizona's Dual Eligible Population

Value in health, 2012-06, Vol.15 (4), p.A15-A15

2012

Volltextzugriff (PDF)

Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 Rearrangement: A US Real-World Chart Review

American journal of clinical pathology, 2023-11, Vol.160 (Supplement_1), p.S93-S94

2023

Volltextzugriff (PDF)

PHP92 EVALUATION OF A WIRELESS HANDHELD MEDICATION MANAGEMENT PROGRAM IN THE PREVENTION OF DRUG-DRUG INTERACTIONS

Value in health, 2009, Vol.12 (3), p.A96-A96

2009

Volltextzugriff (PDF)

Abstract P2-08-66: Outcomes among metastatic breast cancer patients with characteristics that confer a less favorable prognosis

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-08-66

2019

Volltextzugriff (PDF)

PCN150 - Us Burden of Illness Associated With Adjuvant Therapy for Stage I-III Melanoma

Value in health, 2015-05, Vol.18 (3), p.A215-A215

2015

Volltextzugriff (PDF)

PMC3 METHODS FOR ESTIMATING CONFIDENCE INTERVALS OF PER MEMBER PER MONTH (PMPM) UTILIZATION RATES

Value in health, 2008, Vol.11 (3), p.A170-A170

2008

Volltextzugriff (PDF)

PHP28 - The Impact of Generic Substitution on Health Outcomes and Costs: A Systematic Review

Value in health, 2013-11, Vol.16 (7), p.A458-A458

2013

Volltextzugriff (PDF)

Evaluation of Breast Cancer Test-Treatment Strategies Using Decision-Analytic Modeling – Preliminary Results for the 21-Gene Assay Recurrence Score

Annals of oncology, 2013-05, Vol.24, p.iii29

2013

Volltextzugriff (PDF)

Abstract P2-08-38: Influence of prognostic factors on outcomes among metastatic breast cancer patients treated with CDK4&6 inhibitors in routine clinical practice

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-08-38

2019

Volltextzugriff (PDF)

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer

Breast cancer targets and therapy, 2014, Vol.6 (default), p.169-177

2014

Volltextzugriff (PDF)

PHP71 PHARMACY STUDENTS' ABILITYTO RECOGNIZE DRUG-DRUG INTERACTIONS (DDIS)

Value in health, 2008, Vol.11 (3), p.A50-A50

2008

Volltextzugriff (PDF)

PMS65 - Characteristics of Patients Receiving Dmard Therapy for Rheumatoid Arthritis Management

Value in health, 2018-05, Vol.21, p.S201-S202

2018

Volltextzugriff (PDF)

Characteristics of Patients Receiving Dmard Therapy for Rheumatoid Arthritis Management

Value in health, 2018-05, Vol.21, p.S201-S202

2018

Volltextzugriff (PDF)

Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis

Journal of managed care & specialty pharmacy, 2016-02, Vol.22 (2), p.122

2016

Volltextzugriff (PDF)

Patient Preferences Regarding Rheumatoid Arthritis Therapies: A Conjoint Analysis

American health & drug benefits, 2016-04, Vol.9 (2), p.84-93

2016

Volltextzugriff (PDF)

Evaluation of molecular testing patterns in metastatic non-small cell lung cancer at a large U.S. health plan

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e19075-e19075

2014

Volltextzugriff (PDF)

Assessment of single-institution HER2 testing patterns, rate of HER2+ disease, and utilization of trastuzumab in early breast cancer

Journal of clinical oncology, 2013-11, Vol.31 (31_suppl), p.124-124

2013

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

COPD exacerbation frequency and its association with health care resource utilization and costs

The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review

PB2109: REALMIND: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA STARTING SECOND/THIRD‐LINE THERAPY AND NOT RECEIVING A STEM CELL TRANSPLANT

Us Burden of Illness Associated With Adjuvant Therapy for Stage I-III Melanoma

Consideration of international generic distribution policies on patient outcomes in the United States and Germany

The Impact of Generic Substitution on Health Outcomes and Costs: A Systematic Review

PHP13 Impact of Medicare Part D on Pharmaceutical and Medical Utilization in Arizona's Dual Eligible Population

Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 Rearrangement: A US Real-World Chart Review

PHP92 EVALUATION OF A WIRELESS HANDHELD MEDICATION MANAGEMENT PROGRAM IN THE PREVENTION OF DRUG-DRUG INTERACTIONS

Abstract P2-08-66: Outcomes among metastatic breast cancer patients with characteristics that confer a less favorable prognosis

PCN150 - Us Burden of Illness Associated With Adjuvant Therapy for Stage I-III Melanoma

PMC3 METHODS FOR ESTIMATING CONFIDENCE INTERVALS OF PER MEMBER PER MONTH (PMPM) UTILIZATION RATES

PHP28 - The Impact of Generic Substitution on Health Outcomes and Costs: A Systematic Review

Evaluation of Breast Cancer Test-Treatment Strategies Using Decision-Analytic Modeling – Preliminary Results for the 21-Gene Assay Recurrence Score

Abstract P2-08-38: Influence of prognostic factors on outcomes among metastatic breast cancer patients treated with CDK4&6 inhibitors in routine clinical practice

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer

PHP71 PHARMACY STUDENTS' ABILITYTO RECOGNIZE DRUG-DRUG INTERACTIONS (DDIS)

PMS65 - Characteristics of Patients Receiving Dmard Therapy for Rheumatoid Arthritis Management

Characteristics of Patients Receiving Dmard Therapy for Rheumatoid Arthritis Management

Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis

Patient Preferences Regarding Rheumatoid Arthritis Therapies: A Conjoint Analysis

Evaluation of molecular testing patterns in metastatic non-small cell lung cancer at a large U.S. health plan

Assessment of single-institution HER2 testing patterns, rate of HER2+ disease, and utilization of trastuzumab in early breast cancer

Suchergebnisse filtern